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The ER’s capacity to process proteins is lim-
ited, and stress caused by accumulation of un-
folded and misfolded proteins (ER stress) con-
tributes to human disease. ER stress elicits
the unfolded protein response (UPR), whose
components attenuate protein synthesis, in-
crease folding capacity, and enhance mis-
folded protein degradation. Here, we report
that P58IPK/DNAJC3, a UPR-responsive gene
previously implicated in translational control,
encodes a cytosolic cochaperone that associ-
ates with the ER protein translocation channel
Sec61. P58IPK recruits HSP70 chaperones to
the cytosolic face of Sec61 and can be cross-
linked to proteins entering the ER that are de-
layed at the translocon. Proteasome-mediated
cytosolic degradation of translocating proteins
delayed at Sec61 is cochaperone dependent.
In P58IPK/ mice, cells with a high secretory
burden are markedly compromised in their abil-
ity to cope with ER stress. Thus, P58IPK is a key
mediator of cotranslocational ER protein degra-
dation, and this process likely contributes to ER
homeostasis in stressed cells.
INTRODUCTION
Early steps in the biogenesis of secreted and transmem-
brane proteins take place in association with the endo-
plasmic reticulum (ER). Newly synthesized polypeptides
or segments thereof are translocated into the ER lumen,where chaperones and protein-modifying enzymes pro-
mote their conversion into functional proteins that exit
the organelle (Sitia and Braakman, 2003; Anken et al.,
2005). The ER’s capacity to process proteins is relatively
limited, and the stress caused by accumulation of un-
folded and misfolded proteins (ER stress) contributes to
a number of important human diseases (Kaufman, 2002).
Cells respond to ER stress by activating an unfolded
protein response (UPR), which limits new protein synthe-
sis and promotes the expression of genes that enhance
the organelle’s capacity to process unfolded proteins (Pa-
til and Walter, 2001). Degradation of misfolded proteins
represents a third mechanism by which cells limit the bur-
den of unfolded proteins in their ER and assumes great im-
portance when ER function is compromised. A dedicated
machinery targets misfolded proteins to a retrotransloca-
tion channel for subsequent proteasomal degradation in
the cytosol. Early work suggested that the anterograde
translocation of nascent proteins and retrograde translo-
cation of completed misfolded ones were mediated by
the same channel; however, it is presently believed that
these two processes are separated in time and place
and that the degradation of misfolded ER proteins is
largely a posttranslocational event (Tsai et al., 2002;
Meusser et al., 2005).
ApoB100 is a notable exception to this rule. This large
secreted protein normally assembles with lipids in the lu-
men of the ER of liver cells to form a lipoprotein particle
(Fisher and Ginsberg, 2002; Hussain et al., 2003). Lipida-
tion is required for folding of apoB100. A block in lipidation
leads to cotranslocational degradation of apoB100, as
the protein remains associated with the Sec61 channel
(Mitchell et al., 1998; Pariyarath et al., 2001). Furthermore,
whereas the extraction of conventional misfolded lumenal
proteins from the ER is mediated by the multifunctional
ATPase p97/Cdc48 (Ye et al., 2001), the degradation ofCell 126, 727–739, August 25, 2006 ª2006 Elsevier Inc. 727
apoB100 requires cytosolic chaperones of the HSP70 and
HSP90 class (Fisher et al., 1997; Gusarova et al., 2001).
The dependence of apoB100 degradation on cytosolic
chaperones and the association of this process with the
Sec61 channel present intriguing similarities to the pro-
cess by which binding of lumenal HSP70 promotes the
translocation of proteins into the ER (Matlack et al.,
1999). The latter process requires a translocon-associ-
ated DnaJ domain containing cochaperone to stimulate
ATP hydrolysis and peptide binding by the lumenal
HSP70 (Misselwitz et al., 1998); however, no such factor
has been found for cotranslocational degradation of
apoB100.
P58IPK was first discovered as an inhibitor of the virally
induced eIF2a kinase PKR (Barber et al., 1994). The en-
coding gene P58IPK/DnaJC3 was subsequently found to
be UPR inducible (Lee et al., 2003), and P58IPK also binds
and inhibits the ER stress-inducible eIF2a kinase PERK
(Yan et al., 2002; Van Huizen et al., 2003). Given the latter’s
role in attenuating protein synthesis in ER-stressed cells
(Harding et al., 1999), these findings implicated P58IPK in
recovery of protein synthesis following dissipation of ER
stress. However, the phenotype of the P58IPK knockout
is not easy to reconcile with a role restricted to attenuating
eIF2a phosphorylation (Ladiges et al., 2005).
P58IPK/DNAJC3 contains a functional DnaJ domain that
promotes ATP hydrolysis by HSP70 chaperones (Melville
et al., 1999). The bulk of P58IPK consists of nine tetratrico-
peptide (TPR) repeats by which it binds eIF2a kinase(s)
(Lee et al., 1994) and the highly conserved C-terminal seg-
ments of cytosolic HSP70 and HSP90 proteins (Melville
et al., 1999; Brychzy et al., 2003). The study below was de-
signed to address the possibility that, in addition to its
known role as an inhibitor of eIF2a kinases, P58IPK might
also collaborate with cytosolic chaperone networks that
function in ER-stressed cells.
RESULTS
P58IPK’s PERK-Independent Function
PERK’s C. elegans homolog, pek-1, is required for the sur-
vival of worms lacking the IRE1 (ire-1) arm of the unfolded
protein response (Shen et al., 2001). Given that P58IPK in-
hibits PERK (Yan et al., 2002), we were surprised that, not
only did attenuation of worm’s P58IPK homolog (dnj-7) by
RNAi fail to rescue the phenotype of (partial) inactivation of
pek-1 in an ire-1 mutant strain (Figures 1A5, 1A6, and
1A7), but also, on its own, dnj-7(RNAi) markedly reduced
the fitness of ire-1 mutant animals (Figure 1A8). To follow
up on this hint of pek-1 independent function(s) of DNJ-7/
P58IPK, we compared the effects of dnj-7(RNAi) in wild-
type and pek-1-deleted worms. dnj-7(RNAi) increased
basal activity of the ER stress-inducible hsp-4::gfp (BiP)
reporter in both wild-type and pek-1-deleted worms. Fur-
thermore, dnj-7(RNAi) enhanced hsp-4::gfp expression in
worms exposed to the ER stress-promoting drug tunica-
mycin, regardless of their pek-1 genotype (Figures 1B
and 1C).728 Cell 126, 727–739, August 25, 2006 ª2006 Elsevier Inc.These observations indicate that DNJ-7/P58IPK’s role in
ER-stressed cells is not restricted to antagonizing PEK-1/
PERK’s kinase activity. Furthermore, growth retardation
by dnj-7(RNAi) in the mutant ire-1 background suggested
that attenuated DNJ-7/P58IPK expression affects HSP-4
expression indirectly, by increased burden of misfolded
proteins rather than directly by enhancing UPR signaling.
Subsequent experiments were designed to understand
these PERK-independent functions of P58IPK.
P58IPK Is a Peripheral Membrane Protein of the
Rough ER that Associates with SEC61
and HSP70 Chaperones
Recombinant P58IPK expressed in COS1 cells colocalized
with ER markers (Yan et al., 2002). We confirmed this co-
localization by immunostaining the endogenous protein in
mouse fibroblasts (Figure S1A in the Supplemental Data
available with this article online) and extended this analy-
sis by examining P58IPK’s association with subcellular
fractions in mouse liver, a rich source of the protein. The
vast majority of P58IPK from the postmitochondrial super-
natant was recovered in the buoyant membrane fraction
by equilibrium density centrifugation. This association
was disrupted by carbonate extraction, which indicates
that P58IPK is a peripheral membrane protein (Figure 2A).
Hepatocytes have well-differentiated smooth and rough
ERs, which are easily separable. P58IPK comigrated with
the rough ER markers Sec61a and ribophorin I follow-
ing equilibrium density gradient centrifugation (Figure 2B).
Interestingly, P58IPK was also membrane associated in
PERK/ cells (Figure S1B), suggesting that membrane
anchoring of P58IPK entails interactions with a different
rough ER transmembrane protein.
P58IPK liberated from membranes by digitonin and other
mild detergents remained associated with a relatively
large heterogeneous complex that migrates through a ve-
locity gradient as a broad peak (Figure 2C). Unfortunately,
none of the available anti-P58IPK antisera or antibodies
recognize the protein in this intact native complex, pre-
cluding its immunopurification. However, following dena-
turation and complex disassembly, P58IPK is readily rec-
ognizable both by the previously described monoclonal
antibodies and by the polyclonal antiserum we raised to
the bacterially expressed protein (data not shown).
To further characterize this membrane-associated
P58IPK-containing complex, we radiolabeled wild-type
and P58IPK/ fibroblasts, solubilized the membranes in
detergent, and added the lysine-reactive reversible cross-
linker DSP to the lysate. After quenching the crosslinker,
the complex was denatured in urea and SDS, which disso-
ciates noncovalently bound partners and exposes P58IPK
to our antibody. The denaturants were diluted and the
radiolabeled P58IPK was immunoprecipitated along with
covalently bound partners. The addition of crosslinker
yielded a P58IPK-dependent doublet of 40 kDa, along
with other weaker bands (Figure 3A, compare lanes 4
and 5 with lanes 11 and 12). This doublet comigrated
with radiolabeled Sec61a, a central component of the
Figure 1. PERK/pek-1-Independent Ac-
tivity of P58IPK/dnj-7
(A) Photomicrographs obtained 72 hr after
hatching of populations of wild-type (WT) and
ire-1 mutant (ire-1mut) C. elegans that devel-
oped from fertilized eggs placed on bacterial
lawns expressing the indicated RNAi gene con-
structs. The percentage of animals in the pop-
ulation that reached the L4 stage of develop-
ment by 72 hr is indicated below the image.
(B) Fluorescent photomicrographs of the GFP
signal of hsp-4::gfp transgenic animals of
wild-type (WT) or pek-1-deleted (pek-1D) geno-
types exposed to the indicated RNAi con-
structs or tunicamycin (30 mg/ml for 16 hr).
(C) Immunoblots of GFP protein and endoge-
nous HSP-4/BiP (detected with anti-HDEL anti-
body) in lysates of untreated or tunicamycin-
treated hsp-4::gfp transgenic animals of the
indicated genotype and RNAi exposure. The
asterisk marks an unidentified protein detected
by the anti-HDEL antibody.translocon (Figure 3A, lanes 17 and 18) and was reactive
with anti-Sec61a antiserum, as revealed by the contents
of an anti-Sec61a immunoprecipitation performed se-
quentially on the anti-P58IPK immunoprecipitate after re-
versal of the crosslink (Figure 3A, lane 15). Furthermore,
P58IPK copurified with digitonin-solubilized native translo-
cons, isolated by immunoprecipitation with a Sec61b an-
tiserum in the absence of crosslinker (Figure 3B). These
observations suggest that P58IPK molecules are associ-
ated with the translocon.
The tetratricopeptide repeats (TPR) in P58IPK closely re-
semble those found in TPR2, a protein of unknown func-
tion that binds avidly to HSP70 chaperones. P58IPK has
also been noted to form a complex with HSP70 in vitro
(Melville et al., 1999), an observation that we confirmed
(data not shown). TPR-containing proteins bind the con-
served C-terminal tails of cytoplasmic HSP70 chaperones
(Scheufler et al., 2000), and consistent with this obser-
vation, P58IPK was co-eluted with HSP70 by excess ATP
from an ATP-agarose affinity matrix loaded with deter-
gent-solubilized ER membranes (Figure 3C). We also
compared the colocalization of HSP70 chaperones with
translocon components in velocity gradients prepared
with digitonin-solubilized ER membranes from wild-typeand P58IPK/ mouse liver. This mild solubilization proce-
dure, which preserves the integrity of the translocon (Gor-
lich et al., 1992), yielded abundant comigrating HSP70 in
the wild-type but not in the P58IPK/ sample (Figure 3D)
and suggests that P58IPK plays an important role in recruit-
ing chaperones to the cytosolic face of the ER translocon.
P58IPK and Cotranslocational Degradation
of ER Proteins
The retrotranslocation of misfolded/misassembled pro-
teins from the ER and their degradation in the cytoplasm
requires numerous proteins on the cytosolic face of the
ER (Tsai et al., 2002; Meusser et al., 2005); it is also a pro-
cess whose disruption is predicted to promote accumula-
tion of misfolded proteins in the ER lumen. Therefore, we
measured the effect of the P58IPK genotype on degra-
dation of ectopically expressed T cell receptor a chain
(TCRa), a well-characterized indicator of the activity of
the ER retrotranslocation/degradation apparatus (Yu
et al., 1997). In pulse-chase labeling experiments, newly
synthesized TCRa decayed with similar kinetics in trans-
fected wild-type and P58IPK/ cells (Figures 4A and
4B). While the P58IPK genotype did not affect the decay
of mature TCRa after the pulse, the amount of labeledCell 126, 727–739, August 25, 2006 ª2006 Elsevier Inc. 729
TCRa present at the end of the (short) pulse was reproduc-
ibly higher in the P58IPK/ cells. This is unlikely to reflect
differences in transfection efficiency or global protein syn-
thesis, as accumulation of radiolabeled neomycin phos-
photransferase (NPT, encoded by a separate gene on
Figure 2. P58IPK Is a Peripheral Membrane Protein of the
Rough ER
(A) Immunoblots of P58IPK, ribophorin I (RPN 1, an integral ER mem-
brane marker), and eIF2a (a cytosolic marker) in postmitochondrial su-
pernatant (PMS) or membrane fraction (MB) of liver from untreated and
tunicamycin-treated mice; where indicated, the floated membranes
were extracted with Na2CO3.
(B) Immunoblot of P58IPK, ribophorin I (RPN I), and Sec61a (a rough ER
[RER] marker) and Cyp1A1 (a smooth ER [SER] marker) content of frac-
tions of a self-generated OptiPrep equilibrium gradient loaded with
membranes procured by floatation from tunicamycin-treated mouse
liver.
(C) Immunoblots of ribophorin I (RPN I), protein disulfide isomerase
(PDI, a lumenal ER marker), and P58IPK in fractions of a glycerol (veloc-
ity) gradient of digitonin-solubilized membranes of tunicamycin-
treated mouse liver. Where indicated, the solubilized membranes
were further exposed to RIPA or Na2CO3 before loading on the gradi-
ent. The migration of globular proteins of known size through the gra-
dient is indicated.730 Cell 126, 727–739, August 25, 2006 ª2006 Elsevier Inc.the TCRa plasmid) was similar in the two genotypes. Fur-
thermore, the inhibitory effect of P58IPK on the accumula-
tion of 35S-labeled nascent TCRa following a brief labeling
pulse was recapitulated in transfected COS1 cells (Fig-
ure S2). Together, these experiments suggested that
P58IPK is dispensable for the posttranslocational degrada-
tion of mature TCRa but affects early step(s) in the biogen-
esis of ER proteins, prompting us to further explore the
latter aspect.
Interfering with lipidation by blocking the microsomal
triglyceride transfer protein (MTP) disrupts apoB100
translocation into the ER and renders it a substrate for
an unconventional degradation process that initiates at
the translocon and results in the delivery of the nascent
chain to the cytoplasm for proteasomal degradation
(Fisher and Ginsberg, 2002). Given evidence that P58IPK
functions in early steps of ER protein biogenesis, we
chose to explore its effects on apoB100 degradation. Pri-
mary hepatocytes from wild-type and P58IPK/ mice
were pulse-chase labeled in the presence or absence of
an MTP inhibitor. The MTP inhibitor markedly reduced
the level of full-length apoB100 that accumulated at the
end of the pulse and destabilized the protein. This desta-
bilization was prevented by treating cells with a protea-
some inhibitor, as reported previously (Fisher et al.,
1997). These effects of the MTP inhibitor were attenuated
in the P58IPK/ cell, as reflected in the accumulation of
more full-length apoB100 at the end of the pulse and
marked stabilization of the protein during the chase (Fig-
ures 4C and 4D). ApoB48, an alternative product of the
same gene whose biosynthesis is less dependent on lipi-
dation, was less affected by the P58IPK mutation, and the
P58IPK genotype had no effect on total protein synthesis
in the presence or absence of the MTP inhibitor (data
not shown). Furthermore, MTP inhibition increased the
amount of newly synthesized apoB recovered by sequen-
tial co-immunoprecipitation in a crosslinked complex with
P58IPK (Figure 4E). Together, these observations suggest
a direct role for P58IPK in the degradation of apoB100
molecules whose translocation is compromised by defec-
tive lipid transfer.
ApoB100 is a special, ligand-dependent secreted pro-
tein; however, the observation that the amount of TCRa
accumulating at the end of a short labeling pulse was
also negatively affected by the expression of P58IPK
(Figure 4A and Figure S2) suggested that the cochaperone
may contribute to the degradation of conventional ER
proteins early during their biogenesis. However, detection
of the nonglycosylated TCRa intermediate, predicted to
serve as P58IPK’s substrate in this degradation process,
was unreliable (data not shown). Therefore, we sought
a more robust system in which to test whether P58IPK’s
role in cotranslocational degradation is restricted to
apoB100 or if the cochaperone contributes generally to
the degradation of other ER proteins that translocate
inefficiently.
Derivatives of a naturally occurring cyclodepsipeptide,
HUN-7293, have been reported to selectively block the
Figure 3. P58IPK Is Associated with the ER Translocon and Cytosolic HSP70 Chaperones
(A) Autoradiograph of metabolically labeled P58IPK and associated crosslinked proteins immunoprecipitated from wild-type (P58+/+) and P58IPK
knockout (P58/) mouse fibroblast lysate with the indicated antisera. The crosslink was reversed, and the individual radiolabeled proteins in half
of the immunoprecipitated sample were resolved by SDS-PAGE (lanes 1–14). The other half was subsequently immunoprecipitated with antiserum
to Sec61a (lanes 15 and 16) and loaded alongside an anti-Sec61a immunoprecipitate of uncrosslinked labeled lysate (lanes 17 and 18). The position of
P58IPK and Sec61a bands is indicated.
(B) Immunoblot of P58IPK and Sec61a in complexes recovered by an anti-Sec61b immunoprecipitate from digitonin-solubilized purified membrane
fractions of liver from tunicamycin-treated wild-type (+/+) and P58IPK knockout (/) mice. Anti-CHOP antiserum was used to control for the spec-
ificity of the immunoprecipitation procedure, and the Ponceau S stain of the blot reveals the levels of immunoprecipitating IgG heavy chain (IgG HC) in
the samples.
(C) Immunoblot of HSP70 and P58IPK content of complexes purified by ATP-agarose affinity chromatography, or agarose affinity chromatography (as
a specificity control) from detergent-solubilized membranes of tunicamycin-treated mouse liver. The complexes were eluted with MgCl2 and ATP as
indicated.
(D) Immunoblot of P58IPK, Sec61a, HSP70, and protein disulfide isomerase (PDI) in fractions of a sucrose velocity gradient loaded with rough ER
membranes purified from liver of tunicamycin-treated wild-type (P58+/+) and P58IPK knockout (P58/) mice and solubilized with digitonin under
conditions that preserve translocon integrity.Cell 126, 727–739, August 25, 2006 ª2006 Elsevier Inc. 731
Figure 4. P58IPK Is Required for Degrada-
tion of Nonlipidated apoB100 in Hepato-
cytes
(A) Autoradiograph of 35S-labeled HA epitope-
tagged T cell receptor a chain (TCRa) ectopi-
cally expressed in transfected wild-type
(P58+/+) and P58IPK knockout (P58/) mouse
fibroblasts and immunoprecipitated from the
cell lysate at the end of the 30 min metabolic la-
beling pulse or after the indicated period of cold
chase. Radiolabeled neomycin phosphotrans-
ferase II (NPT II) expressed from the same plas-
mid serves as an internal control.
(B) Plot of the TCRa signal from (A).
(C) Autoradiograph of apoB immunoprecipi-
tated from wild-type and P58IPK/ cultured
primary hepatocytes in a pulse-chase labeling
experiment conducted in the presence or ab-
sence of a microsomal transfer protein inhibitor
(MTP-I) or a proteasome inhibitor (P-I). The po-
sitions of apoB100 and apoB48 are indicated.
(D) Plot of the apoB100/apoB48 signal from (C).
(E) Quantification of radiolabeled apoB associ-
ated with P58IPK following crosslinking with
DSP and recovery by sequential immunopre-
cipitation (mean ± SEM), first with anti-P58IPK
serum and then (after reversal of the crosslink)
by anti-apoB serum. Where indicated, the cells
were exposed to oleic acid (OA, to promote lip-
idation) or MTP inhibitor (MTP-I, to block lipida-
tion) and proteasome inhibitor (P-I) to block
apoB degradation. The crosslinker (DSP) was
omitted in sample 5, and the specific anti-
P58IPK and anti-apoB sera were replaced by
the irrelevant anti-CHOP serum in samples 6
and 7. The amount of radiolabeled (apoB) pro-
tein recovered in the sequential immunopurifi-
cation, measured by scintillation counting, is
expressed as a fraction of the total radiolabeled
apoB, recovered by direct immunoprecipita-
tion from a parallel sample. The inset is an im-
munoblot of P58IPK and ribophorin I, demon-
strating that the experimental conditions used
here did not affect protein levels in these cells.translocation of human vascular cell adhesion molecule-1
(VCAM-1) into the ER. The stalled VCAM-1 (which lacks
glycans and migrates faster than the mature form on
SDS-PAGE) is rapidly degraded normally but accumulates
at the translocon if proteasomes are inhibited (Besemer
et al., 2005; Garrison et al., 2005). To determine if P58IPK
affects the fate of human VCAM-1 in cells treated with
a translocation inhibitor, we compared the effects of an
inhibitor, CAM741 (Besemer et al., 2005), on the fate of
metabolically labeled human VCAM-1 expressed from a
recombinant retrovirus in wild-type and P58IPK/ mouse
fibroblasts. Micromolar concentrations of CAM741 led to
accumulation of a higher-mobility form of human VCAM-
1 in the mutant but not in the wild-type cells (Figure 5A,
lanes 5 and 6). A species of indistinguishable mobility ac-
cumulated in both wild-type and mutant CAM741-treated732 Cell 126, 727–739, August 25, 2006 ª2006 Elsevier Inc.cells when exposed to a proteasome inhibitor (Figure 5A,
lanes 7 and 14). The latter corresponds to the labile, non-
glycosylated pre-VCAM-1 whose translocation is blocked
by the inhibitor (Besemer et al., 2005; Garrison et al.,
2005). A slightly faster-migrating species, presumed to re-
flect translocated but unglycosylated VCAM-1, whose
signal peptide had been cleaved, was observed in cells
treated with the glycosylation inhibitor tunicamycin
(Figure 5A, lane 15; and Figure S3). Furthermore, at lower
concentrations (50–200 nM) CAM741 was less effective in
blocking the accumulation of mature, glycosylated
VCAM-1 in cells lacking P58IPK (Figure 5A, compare lanes
2–4 with 9–11).
COS1 cells express low levels of detectable endoge-
nous P58IPK (Figure 5B); therefore, we examined the effect
of enforced expression of P58IPK on the fate of VCAM-1 in
Figure 5. P58IPK Promotes Cotransloca-
tional Extraction of Human VCAM-1 in
Cells Exposed to a Specific Transloca-
tion Inhibitor
(A) Autoradiogram of metabolically labeled hu-
man VCAM-1 expressed from a recombinant
retrovirus in P58IPK+/+ and P58IPK/ mouse fi-
broblasts. The cells were exposed to the indi-
cated concentration of CAM741 (‘‘CAM’’), tuni-
camycin (Tm), or proteasome inhibitor (P-I) for
the duration of the 4 hr labeling pulse, followed
by lysis and immunoprecipitation with a rabbit
immune serum that recognizes both translo-
cated (glycosylated [‘‘G’’]) and nontranslocated
(nonglycosylated [‘‘N’’]) VCAM-1. The mature
VCAM-1 signal was quantified in each lane
and is expressed as a fraction of the signal in
untreated cells.
(B) Autoradiogram of metabolically labeled
human VCAM-1 expressed by transfection in
COS1 cells or coexpressed together with wild-
type P58IPK (FL) or mutant P58IPK lacking the ef-
fector J domain (DJ). The cells were treated with
CAM741 as in (A). The lower panel is an autora-
diograph of P58IPK (full-length [FL] and mutant
[DJ]), immunopurified from the flow-through of
the VCAM-1 immunopurification.
(C) Autoradiogram of radiolabeled VCAM-1 as-
sociated with P58IPK in cotransfected COS1
cells, following crosslinking with DSP and re-
covery by sequential immunoprecipitation, first
with anti-P58IPK serum and then (after reversal
of the crosslink and denaturation of the sample)
by anti-VCAM-1 serum. The cells were exposed
to CAM741 (1 mM to inhibit VCAM-1 transloca-
tion) and proteasome inhibitor to block degra-
dation of the stalled VCAM-1. CAM741 was
omitted in lane 2, the crosslinker (DSP) was
omitted in lane 3, the specific anti-P58IPK and
anti-VCAM sera were replaced with the irrele-
vant anti-CHOP serum in lanes 7 and 8, and
a truncated form of VCAM-1 lacking the signal
peptide (VCAM-1DSP) was used in lanes 9 and
10. Lanes 11–15 are of VCAM-1 immunopuri-
fied from the flow-through of lanes 1–3 and
9–10, as indicated. The asterisk marks an un-
identified protein that is variably immunopuri-
fied with the VCAM-1 antisera and may repre-
sent a degradation product.these cells (characterization of VCAM-1 proteins in COS1
cells is presented in Figure S3). Wild-type, but not mutant
P58IPKDJ (lacking the effector J domain), sensitized COS1
cells to the inhibitory effects of CAM741 on mature human
VCAM-1 expression (Figure 5B), indicating that P58IPK
can be limiting for the inhibitory effect of CAM741.
To further characterize the interaction between P58IPK
and VCAM-1, we determined the effect of CAM741 on
the recovery of VCAM-1 in a crosslinked complex with
P58IPK by sequential immunoprecipitation from radiola-beled COS1 cells that had been treated with a proteasome
inhibitor. A crosslinker-dependent and antisera-depen-
dent radiolabeled band of similar mobility to nonglycosy-
lated VCAM-1 was recovered in complex with P58IPK in
cells treated with CAM741 (Figure 5C). Neither mature
VCAM-1 nor a truncated VCAM-1 lacking the signal pep-
tide interacted with P58IPK, arguing against postlysis asso-
ciations. Together, these observations point to a direct role
for P58IPK in extraction of nascent human VCAM-1 from
the translocon under conditions in which translocation isCell 126, 727–739, August 25, 2006 ª2006 Elsevier Inc. 733
partially inhibited and in delivery of the stalled protein to
the downstream degradation machinery when translo-
cation is completely inhibited.
An ER Stress Disease Model Uncovers
a Requirement for P58IPK
To determine if P58IPK’s role in degrading proteins that are
delayed at the translocon correlates with a physiologically
significant impairment in coping with ER stress, we turned
to the P58IPK knockout mice. As an isolated mutation in
a C57BL/6 background, P58IPK+/ animals are normal
and P58IPK/mice have a very mild phenotype, manifest-
ing as a mild delay in postnatal growth in both sexes and
subclinical glucose intolerance developing in males by
6 months of age, which progresses to fasting hyperglyce-
mia at 1 year of age in some animals (Ladiges et al., 2005;
Figure 6).
The ‘‘Akita’’ mutation, C96Y in the A chain of the Ins2
gene product, leads to pro-insulin misfolding and compro-
mised ER function. The b cell adapts to this stress by
activating the UPR, and on the C57BL/6 background
Ins2+/C96Y ‘‘Akita’’ animals are fairly well compensated;
females are virtually asymptomatic and males develop
progressive glucose intolerance culminating in a well-
tolerated nonketotic chronic hyperglycemia (Oyadomari
et al., 2002). Induction of P58IPK is part of the adaptation
of Ins2+/C96Y ‘‘Akita’’ b cells to ER stress, as reflected in el-
evated P58IPK staining in the affected endocrine pancreas
(Figure 6A). Therefore, we chose to examine the impor-
tance of P58IPK in this well-characterized ER stress-
mediated disease model.
Compared to Ins2+/C96Y;P58IPK+/ mice (which are
themselves indistinguishable from Ins2+/C96Y;P58IPK+/+),
Ins2C96Y/+;P58IPK/ mice were dramatically compro-
mised: their growth as pups was severely retarded, and
overt hyperglycemia set in within days after weaning in
both sexes (Figure 6B). The elevated blood glucose was
not met by a corresponding increase in plasma insulin;
rather, plasma insulin levels were very low (Figure 6C),
a finding that correlates with dramatic loss of islet mass
(Figure 6D). These findings indicate that P58IPK has an im-
portant role in preserving function of ER-stressed b cells.
The phenotype of the compound mutant mice is consis-
tent with a role for P58IPK-mediated cotranslocational
degradation in promoting survival of ER-stressed b cells.
However, the evanescence of the islets in the compound
mutant mice precluded more detailed characterization of
P58IPK’s role in that system. Therefore, to explore the po-
tential effect of ER stress on P58IPK activity, we compared
the physical interaction between P58IPK and metabolically
labeled nascent proteins in unstressed and ER-stressed
cultured fibroblasts. Confining the analysis to nascent
proteins favors detection of interactions between P58IPK
and its clients (over interactions with radiolabeled mature
cofactors). To avoid the confounding effects of changing
levels of P58IPK, we induced ER stress with a brief pulse
of thapsigargin (an agent that adversely affects the protein
folding environment in cells within minutes of application)734 Cell 126, 727–739, August 25, 2006 ª2006 Elsevier Inc.and we minimized the inhibitory effect of ER stress on
protein synthesis by conducting the experiment in the
presence of serum (Harding et al., 1999).
Cells were untreated or pretreated with thapsigargin for
30 min followed by a brief 10 min labeling pulse conducted
in the presence of a low concentration of puromycin. The
latter integrates randomly into radiolabeled nascent
chains, releasing them from the ribosome with a covalent
bound C-terminal puromycin moiety that is reactive with
a specific antiserum (Zhang et al., 1997). Following solubi-
lization with digitonin and crosslinking with DSP, the lysate
was denatured in 2% SDS, disrupting noncovalent inter-
actions. The SDS was diluted and P58IPK (and associated
radiolabeled proteins) was immunoprecipitated. The anti-
P58IPK immune complex was disrupted with 2% SDS,
crosslinks reversed with DTT, and the radiolabeled, na-
scent, puromycinylated proteins were captured by a
second immunoprecipitation reaction with an antisera to
puromycin and quantified by scintillation counting. Inter-
estingly, exposure to thapsigargin resulted in a 1.6-fold
increase in the fraction of puromycinylated (nascent) pro-
teins recovered in complex with endogenous P58IPK
(Figure 7A).
Several controls were included: the signal detected by
sequential immunoprecipitation in cells radiolabeled in
the absence of puromycin was negligible (Figure S4),
and the experiment was conducted in P58IPK/ cells, in
which thapsigargin did not increase recovery of puromyci-
nylated proteins in the anti-P58IPK immune complex. Ex-
posure of wild-type cells to arsenite, an agent that mimics
the effects of ER stress on the translational apparatus
(reflected in eIF2a phosphorylation [see inset]) but causes
little or no ER stress, very modestly increased complex
formation (1.1-fold). Finally, combining, before crosslink-
ing, lysates made from radiolabeled, thapsigargin, and
puromycin-treated P58IPK/ cells and nonlabeled lysates
from thapsigargin-treated wild-type cells yielded a low
background signal, suggesting that the interactions im-
mortalized by the crosslinking procedure do not reflect
a postlysis artifact. While other interpretations cannot be
excluded, the observation that most of the endogenous
P58IPK in cells is associated with RER membranes (Fig-
ure 2), suggests that the puromycinylated proteins associ-
ated with it are translocation substrates. This experiment
is therefore consistent with an ER stress-mediated en-
hancement of P58IPK’s interactions with its client proteins.
DISCUSSION
Previously characterized as a stoichiometric inhibitor of
the stress-inducible eIF2a kinases PKR and PERK,
P58IPK emerges from these studies as having a broader
role in the ER.
P58IPK and Degradation of Stalled
Translocation Substrates
Studies of several model proteins have shown that their
degradation occurs after dissociation from the translocon
Figure 6. Loss of P58IPK Sensitizes Mice
to ER Stress-Induced Diabetes Mellitus
(A) Immunostaining of P58IPK and insulin in sec-
tions of pancreas obtained from wild-type
(Ins2+/+) and ‘‘Akita’’ mutant mice (Ins2+/C96Y).
The H33258 signal reports on all the nuclei in
the field.
(B) Time-dependent changes in blood glucose
levels and body weight of male and female
mice with the indicated P58IPK and Ins2 geno-
types. Shown are means ± SD (n = 6; *p <
0.05 for Ins2C96Y;P58+/ versus Ins2C96Y;
P58/). Note that the compound mutant ani-
mals all died between 6 and 12 weeks.
(C) Plots of plasma insulin and blood glucose of
3-week-old female mice. Shown are means ±
SD (n = 5; *p < 0.05).
(D) Photomicrographs of the pancreas of
3-week-old female mice with the indicated
genotypes.and release into the lumen (in the case of soluble proteins)
or after lateral gating and partitioning into the lipid bilayer
(in the case of integral membrane proteins). A retrotranslo-
cation apparatus with components conserved in all eu-
karyotes identifies the misfolded protein and recruits it
to a channel that is likely distinct from the translocon.Following channel engagement and with the assistance
of cytosolic partners, the misfolded protein is retrotranslo-
cated, polyubiquitinated, and delivered to the proteasome
for degradation (Tsai et al., 2002; Meusser et al., 2005). We
have no evidence that P58IPK contributes to this process;
rather, P58IPK helps degrade proteins at the translocon, asCell 126, 727–739, August 25, 2006 ª2006 Elsevier Inc. 735
Figure 7. Increased Association of En-
dogenous P58IPK with Nascent Polypep-
tides in ER-Stressed Cells
(A) Quantification of radiolabeled nascent (puro-
mycinylated) proteins associated with endog-
enous P58IPK following crosslinking with DSP
and recovery by sequential immunoprecipita-
tion, first with anti-P58IPK serum and then (after
reversal of the crosslink and dissociation of the
immune complex) by anti-puromycin serum.
Where indicated, mouse fibroblasts of wild-
type and knockout P58IPK genotype were
treated with thapsigargin (Tg, 100 nM, to in-
duce ER stress) or arsenite (25 mM, as a cyto-
solic stress control). The crosslinker (DSP)
was omitted from sample 3, and radiolabeled
extracts from / cells were combined with
nonlabeled extracts from +/+ cells prior to
crosslinking in sample 7 (labeled <=>). The
amount of radiolabeled puromycinylated pro-
tein recovered in the sequential immunopurifi-
cation was measured by scintillation counting
and is expressed as a fraction of the total radio-
labeled puromycinylated proteins, recovered
by direct immunoprecipitation. Shown are the
mean and range of an experiment performed
in duplicate and repeated four times. The inset
is that of a P58IPK and P-eIF2a blot of lysates of
cells exposed to thapsigargin or arsenite.
(B) Cartoon depicting P58IPK’s hypothesized
role at the translocon. In unstressed cells with
ample reserves of lumenal chaperones (BiP
and associated J domain cofactors), protein
translocation proceeds efficiently. The ribo-
some-translocon junction is closed, and
P58IPK is inactive (left panel). In ER-stressed
cells (right panel), accumulation of misfolded
protein challenges lumenal chaperone reserves. The resulting inefficient protein translocation favors disruption of the ribosome-translocon seal
and exposure of the cytosolic portion of the translocating polypeptide to P58IPK. The latter recruits cytosolic HSP70s to the translocon and presents
the client protein to them, thus promoting its extraction from the lumen through ATP hydrolysis, possibly by a ratcheting mechanism involving sequen-
tial binding of HSP70 molecules.exemplified by its role in the degradation of apoB100
and VCAM-1.
ApoB100 degradation occurs while the protein remains
associated with the translocon (Mitchell et al., 1998; Par-
iyarath et al., 2001); however, the process is incompletely
understood. Especially obscure is the mechanism by
which cytosolic proteins such as the chaperones known
to assist in apoB100 degradation (Fisher et al., 1997; Gu-
sarova et al., 2001) might gain access to the polypeptide.
Engagement of the substrate at the translocon shields it
from reactive probes applied to the cytosol side, findings
that imply a tight ribosome-translocon junction (Crowley
et al., 1994; Jungnickel and Rapoport, 1995). However,
mounting evidence suggests that the seal on the ribo-
somal side might be modulated by events in the channel
or possibly more distally in the lumen of the ER. For exam-
ple, the signal sequence can influence the nascent chain’s
accessibility on the cytosolic side; when appended to
a model translocated substrate, the efficient signal se-
quence from prolactin specifies a tight ribosome-translo-
con junction, whereas the weaker signal sequence of the736 Cell 126, 727–739, August 25, 2006 ª2006 Elsevier Inc.prion-related protein specifies a weaker seal (Fons et al.,
2003). Translocating apoB is likewise accessible to
probes applied to the cytosolic side (Hegde and Lingappa,
1996).
While the relationship of accessibility on the cytosolic
side to lipidation (and folding) on the lumenal side has
not been explored directly, it is conceivable that misfold-
ing associated with impaired lipidation retards transloca-
tion and disrupts the seal at the ribosome translocon junc-
tion. This, in turn, is predicted to expose the protein to
P58IPK, which is supported by the observation that inhibi-
tors of lipidation increase the amount of radiolabeled apoB
recovered in complex with P58IPK (Figure 4E). We propose
that P58IPK uses its C-terminal DnaJ cochaperone domain
to promote HSP70 chaperone binding to exposed regions
of proteins whose translocation is delayed for any reason.
Cycles of P58IPK-coordinated cytosolic chaperone bind-
ing extract the misfolded substrate from the translocon
by a ratcheting mechanism similar to that used by lumenal
chaperones to promote anterograde translocation (Mat-
lack et al., 1999).
The fate of VCAM-1 in cells exposed to low concentra-
tions of the translocation inhibitor suggests that transloca-
tion and P58IPK-mediated extraction (and degradation) are
competing processes and that the partitioning of the sub-
strate between these two fates is sensitive to the level of
P58IPK (and therefore modulated by the UPR). Accumula-
tion of cytosolic VCAM-1 was only observed in knockout
cells exposed to high concentrations of the inhibitor; at
lower concentrations of inhibitor reduced expression of
mature VCAM-1 was also observed in the mutant cells,
but this was not associated with the accumulation of the
nonglycosylated form (Figure 5A, lanes 3 and 4). These
findings are consistent with the existence of (saturable)
P58IPK-independent mechanisms for degrading sub-
strates that fail to translocate and would otherwise
accumulate on the cytosolic face of the ER membrane.
Cotranslocational Degradation and ER Stress
Cotranslational translocation can proceed without lu-
menal chaperones, at least in vitro (Gorlich and Rapoport,
1993). However, their contribution to the efficiency of
the process is suggested by observations that BiP and
its translocon-associated J domain-containing cofactor,
Sec63, are required in an in vitro reconstituted system
that translocates proteins posttranslationally (Matlack
et al., 1999) and in an in vitro system for cotranslational
translocation (Brodsky et al., 1995). Furthermore, inactiva-
tion of BiP/Kar2p by a tsmutation leads to accumulation of
translocation substrates in the yeast cytosol in vivo (Vogel
et al., 1990). Based on these observations we propose
that, under conditions of ER stress, translocation is com-
promised by limited lumenal chaperone reserve. As a con-
sequence, diverse ER proteins, delayed at the translocon,
become substrates for extraction and degradation medi-
ated by P58IPK and its cytosolic HSP70 partners. This
speculation is supported by the observation that ER stress
increases the association of nascent (puromycinylated)
proteins with P58IPK (Figure 7A). Therefore, we propose
that the induction of P58IPK in ER-stressed cells repre-
sents an attempt to shift the equilibrium in favor of extrac-
tion from the translocon and cytosolic degradation of
proteins as outlined in cartoon form (Figure 7B).
P58IPK knockout results in increased misfolded protein
burden in the ER lumen and higher levels of ER stress sig-
naling (Figure 1B and Figure S5). The markedly impaired
survival of b cells of P58IPK/;Ins2+/C96Y ‘‘Akita’’ mice,
compared with ‘‘Akita’’ mice with a functional P58IPK al-
lele, is consistent with the importance of cotranslocational
degradation in protecting the stressed ER of secretory
cells (though other roles for P58IPK cannot be excluded).
This protective effect might reflect a reduction in protein
flux into the stressed ER’s lumen. Alternatively, as the
folding of complex proteins often entails interactions be-
tween distant segments on the linear polypeptide chain,
stalled translocating proteins remain unfolded and engage
chaperones on the lumenal side. The first line of defense
against this threat is the PERK-mediated attenuation of
translation initiation, which has no negative consequenceson the processivity of translation or translocation and
therefore on the rate of protein folding. Our studies sug-
gest that P58IPK induction represents a second line of de-
fense, which by extracting stalled translocation substrates
frees the bound lumenal chaperones to engage in other
tasks and clears the translocon from obstructing diffi-
cult-to-fold polypeptides.
EXPERIMENTAL PROCEDURES
Cell Culture, Transfection, and Treatment
P58IPK/ and P58IPK+/+ mouse embryo fibroblasts were prepared
from embryonic day 13.5 progeny of heterozygous knockout mice (La-
diges et al., 2005). Radiolabeled HA-tagged TCRa, NHK-AT, and wild-
type or DJ mutant (1-393) mouse P58IPK was expressed by transient
transfection using the FuGENE 6 lipid-mediated gene transfer (Roche)
in fibroblasts and the DEAE-dextran method for COS1 cells and de-
tected by immunoprecipitation as previously described (Yu et al.,
1997). Mammalian expression plasmids for human VCAM-1 and its
truncated derivative have been previously described (Besemer et al.,
2005; Garrison et al., 2005).
Antisera, Immunoblotting, Immunoprecipitation,
and Immunostaining
Antiserum to mouse P58IPK (NY1165) was raised by injecting a rabbit
with full-length mouse P58IPK expressed in E. coli as a GST fusion pro-
tein and cleaved by thrombin. Its use in immunostaining is described is
detail in Figure S1A. Insulin immunoreactivity was detected as previ-
ously described (Oyadomari et al., 2002).
Rabbit anti-mouse CYP1A1 was a gift of Virginia Black (NYU), antise-
rum to puromycin was a gift of Peter Walter (UCSF), and antiserum to
human VCAM-1 and ribophorin I were raised in rabbit against the bac-
terially expressed protein. Other antisera were purchased from com-
mercial sources and used according to the vendor’s specifications:
rabbit anti-human a-1-Antitrypsin (DAKO), rabbit anti-GFP (Molecular
Probe), mouse anti-HSP70/HSC70 (Stressgen), rabbit anti-neomycin
phosphotransferase II (NPT II; US Biological), mouse anti-PDI (Stress-
gen), rabbit anti-Sec61a (Affinity BioReagents), and anti-phospho-
eIF2a (BioSource).
Subcellular Fractionation, Protein Purification, and Crosslinking
The liver of the untreated or tunicamycin-treated mice (i.p. injection,
1 mg/kg body weight, 16 hr) was mechanically disrupted by Teflon
glass homogenizer in homogenization buffer (20 mM Tris-HCl [pH
7.5], 5 mM MgCl2, 1 mM dithiothreitol, 250 mM sucrose, 10 mg/ml cy-
cloheximide, 1 mM PMSF, 4 mg/ml aprotonin, and 2 mg/ml pepstatin A),
and the postmitochondrial supernatant (PMS) was isolated by centrifu-
gation. The PMS was adjusted to 30% OptiPrep (Axis-Shield), and total
membranes were floated by centrifugation (250,0003 g, 3 hr) on 25%
OptiPrep. After dilution of the OptiPrep and pelleting (100,000 3 g,
1 hr), the membranes were resuspended in homogenization buffer
containing 20% OptiPrep and subjected to equilibrium density centri-
fugation (350,000 3 g, 2 hr) in a self-generated OptiPrep gradient to
separate rough and smooth ER. Rough ER was recovered by pelleting
the relevant membrane fraction, translocons were solubilized in 3%
digitonin (Calbiochem), and the soluble material was subjected to non-
equilibrium (velocity) gradient centrifugation in a 15%–50% sucrose
gradient as described (Gorlich et al., 1992).
HSP70 proteins were purified from the digitonin-solubilized mem-
brane preparation by ATP-agarose affinity chromatography and eluted
in 5 mM MgCl2 with or without 20 mM ATP.
Crosslinking of P58IPK to translocon components was assayed in
wild-type orP58IPK/ fibroblasts labeled for 16 hr with 35S-Translabel,
solubilized in 3% digitonin, and exposed to varying concentrations of
dithio-bis-succinimidylpropionate (DSP, Pierce) on ice for 60 min. AfterCell 126, 727–739, August 25, 2006 ª2006 Elsevier Inc. 737
quenching the unreacted DSP with 100 mM Tris-HCl (pH 7.5), the
sample was denatured by exposure to 6 M urea and 2% SDS at
37C. Following 203 dilution of the denaturants, P58IPK was immuno-
precipitated in RIPA buffer. The crosslink was reversed by incubating
the sample in 100 mM dithiothreitol, 6 M urea, and 2% SDS at 37C (we
found that heating the sample led to substantial loss of Sec61a immu-
noreactivity). Half the sample was set aside for loading on an SDS-
PAGE and the other half was diluted again and immunoprecipitated
with antiserum to Sec61a, reduced, and denatured as described
above and applied to the same SDS-PAGE. Under these conditions,
Sec61a migrates as a doublet on SDS-PAGE (given the lack of S-S
bonds or glycosylation sites, we attribute this heterogeneity to incom-
plete denaturation at the relatively low temperature required to retain
solubility).
Detection of metabolically labeled apoB was adapted from the pub-
lished procedure (Fisher et al., 1997) to accommodate the use of pri-
mary hepatocytes isolated from C57BL/6 adult male mice of wild-
type and P58IPK/ genotypes and cultured on type I collagen-coated
plates in Waymouth’s medium supplemented with 0.1 nM insulin. Cells
were switched to DMEM with 10% of the normal methionine and cys-
teine content 30 min before addition of 35S-TRANSlabel (MP Biomed-
icals) at 250 mCi/ml for 30 min, followed by cold chase. Cells were pre-
treated with 10 mM lactacystin (Boston Biochem) for 30 min and then
treated with the MTP inhibitor (50 mM CP10447; Pfizer) and 10 mM lac-
tacystin as indicated. Radiolabeled apoB was immunoprecipitated
with antiserum raised to mouse apoB.
Radiolabeled apoB in complex with P58IPK was isolated from rat
McA-RH7777 hepatoma cells by adapting a procedure to detect com-
plexes of apoB and Sec61 (Pariyarath et al., 2001). The cells were met-
abolically labeled in the presence of proteasome inhibitor as above,
treated with digitonin (Calbiochem), and exposed to DSP crosslinker.
Quenching, complex disruption, and sequential immunoprecipitation
were conducted as described above (for Sec61a). The total amount
of apoB synthesized was recovered by immunoprecipitation from
a parallel sample of cells + supernatant, and the fraction of apoB re-
covered in complex with P58IPK was determined as the ratio of the
two measurements.
VCAM-1 biogenesis was followed by pulse-labeling and immuno-
precipitation. Wild-type and P58IPK/ mouse fibroblasts were in-
fected with a recombinant retrovirus encoding human VCAM-1,
whereas COS1 cells were transfected with a plasmid encoding
VCAM-1, alongside plasmids encoding wild-type or DJ mutant mouse
P58IPK. Two days after gene transduction, the cells were exposed to
varying concentrations of CAM741 (50 nM–10 mM) in the presence or
absence of proteasome inhibitor or tunicamycin, as described (Be-
semer et al., 2005), radiolabeled for 4 hr, and immunoprecipitated
with a rabbit polyclonal serum raised against the bacterially expressed
protein that detects both native and nonnative human VCAM-1.
Complexes between human VCAM-1 and P58IPK were detected in
cotransfected COS1 cells as described above. CAM741 (1 mM) and
MG132 (10 mM) were added to the culture media 30 min before and
throughout the 2 hr 35S-TRANSlabel (ICN; 250 mCi/ml) labeling pulse.
Complex solubilization, crosslinking, and sequential immunoprecipi-
tation were performed as described above for the analysis of P58IPK
and Sec61a complexes.
The methods used to purify and detect complexes between puro-
mycinylated (nascent) proteins and P58IPK in mouse fibroblasts are
described in detail in the Results section. Metabolic labeling was
performed in methionine minus DMEM with 10% dialyzed fetal calf
serum. Puromycin (Calbiochem; 0.3 mM) and 35S-TRANSlabel (ICN;
250 mCi/ml) were added for 10 min before solubilization in digitonin
and crosslinking.
C. elegans Genetics and Procedures
The ire-1(zc14)II mutant and hsp-4::gfp(zcIs4)V BiP-promoter GFP re-
porter fusion strains are available from the Caenorhabditis Genetics
Center. The pek-1 (PERK) deletion strain pek-1(zcdf2)X was bred into738 Cell 126, 727–739, August 25, 2006 ª2006 Elsevier Inc.the hsp-4::gfp(zcIs4)V background using standard procedures. To
study the effect of gene inactivation on larval development, gravid ho-
mozygous ire-1(zc14)II mutant animals were treated with bleach to re-
lease fertilized eggs, 100 of which were placed on a lawn E. coli trans-
formed with the pPD129.36 plasmid expressing double-stranded RNA
to pek-1 or dnj-7 (P58IPK), or a mixture of both. The plates were photo-
graphed 72 hr later, and the fraction of progeny that reached the L4
stage was determined by counting individual animals.
Experimental Diabetes Mellitus in the Mouse
All experiments in mice were approved by the IACUC. ‘‘Akita’’ mice
bearing the C96Y mutation in Ins2 were purchased from Jackson
Labs and were bred onto the P58IPK knockout background (Ladiges
et al., 2005) to create Ins2C96Y/+;P58IPK/+ animals. As P58IPK+/
mice are indistinguishable from the wild-type, Ins2C96Y/+;P58IPK/+
animals were then crossed with Ins2+/+;P58IPK/ to yield compound
animals with combinations of Ins2+/+, Ins2C96Y/+, P58IPK+/, and
P58IPK/ genotypes. Glycemic control was assessed weekly by mea-
suring morning blood glucose. Plasma insulin levels were measured at
sacrifice. Pancreata were fixed in 10% formaldehyde, paraffin embed-
ded, sectioned in 5 mm, and stained with hematoxylin and eosin or im-
munostained for insulin and P58IPK. Statistical analysis was performed
by the unpaired two-tailed Student’s t test.
Supplemental Data
The Supplemental Data include five figures and can be found with this
article online at http://www.cell.com/cgi/content/full/126/4/727/DC1/.
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